Wilson Creek Winery and Vineyards
35960 Rancho California Road, Temecula, CA
Friday, September 18, 2015 7:30am – 3:30pm
Emerging Infectious Diseases
This program will deliver the latest breaking news and information on current emerging infections in Infection Prevention for both inpatient and outpatient locations. This educational program is for professionals in Infection Prevention, Surgery, Anesthesiology, Nursing, OR staff, Environmental Services, Home Health, Long Term Care, Ambulatory Care, and Ambulatory Surgical Centers. 6.0 Hours of CEU credits will be provided for this event. There will be a vendor fair, raffle prizes and wine tasting at end of the event.
- 7:30 to 8:00 Registration, Breakfast &Vendor Displays
- 8:00 to 8:10 Welcome and Announcements
- 8:10 to 9:00 Diane Kawa, Ph.D., SM(ASCP) MERS: A Regional Disease with Global Implications
- 9:00 to 9:50 Kim Delahanty, BSN, PHN, MBA-HCM, CIC Ebola from an Emergency Management Perspective
- 9:50 to 10:20 Break and Vendor Fair
- 10:20 to 11:10 Patrick Maroney Vaccine update: Cdiff and more
- 11:10 to 12:00 Eric McDonald MD, MPH, FACEP – Title
- 12:00 to 1:00 Lunch Buffett and Vendor Fair
- 1:00 to 1:50 Rekha Murthy MD Antimicrobial Stewardship and Emerging MDROs
- 1:50 to 2:10 Break and Vendor Fair
- 2:10 to 3:00 Frank Myers MA CIC ERCP Scope Outbreak and Quality Assurance
- 3:00 to 3:30 Closing Comments/Evaluations/CEU Distribution/Door Prizes
Download Presentations for this Conference:EVENT DOCUMENTS
To register as a participant:CLICK HERE
To reserve a vendor table:CLICK HERE
Diane Kawa, Ph.D., SM(ASCP)
Dr. Diane Kawa is Director of Scientific Affairs at BD Life Sciences – Diagnostics Systems. Dr. Kawa received her PhD in Infectious Diseases and Immunity from the University of California, Berkeley and an MS degree in Medical Microbiology from the University of Wisconsin, Madison. She is a Specialist Microbiologist with the American Society for Clinical Pathology and American Society for Microbiology. In her current role at BD, Dr. Kawa works with infectious disease thought leaders, clinical microbiologists and hospital epidemiologists to understand new trends in molecular diagnostics, epidemiology, patient management & infection control. She also manages educational activities and several research collaborations aimed at advancing clinical and scientific knowledge concerning BD’s products for diagnosis of infectious diseases.
Kim Delahanty, BSN, PHN, MBA-HCM, CIC
Kim Delahanty has been Director of Infection Prevention Clinical Epidemiology & TB Control at UCSD Health Systems since 2004 and has expert knowledge in all facets of her field. She is Past President of both San Diego & Imperial Co. APIC and California APIC Coordinating Council (CACC). She is currently serving as on the Board of Directors for National APIC. Kim has published multiple articles and given multiple media interviews, completed countless webinars and numerous speaking engagements both nationally and internationally on infection prevention and clinical epidemiology. She helped create the UCSD Infectious Disease Care Unit which has been approved by CDC as a designated Ebola Treatment facility
Patrick is the Deputy Director and Medical Science Liaison for Sanofi Pasteur based in San Diego. He is the scientific expert for vaccines and pharmaceuticals portfolios, as well as the infectious diseases liaison to FDA, CDC and national governing bodies. During his career, he has helped launch twelve new biologicals and pharmaceuticals.
Eric McDonald MD, MPH, FACEP
Dr. Eric C. McDonald earned a BA from Williams College in 1981 and received his MD from the Uniformed Services University of the Health Sciences in 1985. He completed his residency in Emergency Medicine at Naval Medical Center, San Diego and served a total of 24 years on active duty in the United States Navy, including two combat tours in Operation Iraqi Freedom. After retiring from the Navy in 2005, he practiced emergency medicine at Naval Medical Center, San Diego until completing his MPH at San Diego State University in 2010. He joined County of San Diego Health and Human Services Agency (HHSA) in 2010 and is currently the Medical Director of the Epidemiology and Immunizations Services Branch, Public Health Services, HHSA
Rekha Murthy MD, FRCP(C), FACP, FIDSA, FSHEA
Rekha Murthy is Medical Director of the Hospital Epidemiology Department and Professor of Medicine in the Division of Infectious Diseases at Cedars-Sinai Medical Center and Professor of Clinical Medicine at the University of California at Los Angeles (UCLA) David Geffen School of Medicine in Los Angeles, CA.. She is board certified in internal medicine and infectious diseases. Dr. Murthy’s clinical and research interests include the prevention of hospital acquired infections, epidemiology of multidrug resistant organisms, antimicrobial management and device associated infections. At Cedars-Sinai, Dr. Murthy serves as Chair of the Infection Control and Antibiotic Utilization Review Committees and leads the hospital-wide efforts to prevent healthcare associated infections, develop strategies to address new relevant public health regulations and to address the institutional response to emerging communicable disease threats such as novel H1N1, bioterrorism and multi-drug resistant organisms. Dr. Murthy has written numerous articles, book chapters and abstracts and has lectured nationally and internationally on infectious diseases
Frank Myers MA, CIC
Frank started his career in HIV/AIDs surveillance for the State of Delaware. He then moved to California and took on the role of Director of Clinical Epidemiology and Safety Systems at Scripps Mercy Hospital for 18 yrs. He has recently moved to UCSD Health Systems as a lead Infection Preventionist. Frank has extensive experience in Hospital epidemiology, including many professional presentations and publications.